Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1940-0640
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach ; volume:15 ; number:1 ; day:15 ; month:1 ; year:2020 ; pages:1-6 ; date:12.2020
Addiction science & clinical practice ; 15, Heft 1 (15.1.2020), 1-6, 12.2020
- Creator
-
Rozylo, Jennifer
Mitchell, Keren
Nikoo, Mohammadali
Durante, S. Elise
Barbic, Skye P.
Lin, Daniel
Mathias, Steve
Azar, Pouya
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13722-020-0177-x
- URN
-
urn:nbn:de:101:1-2020042003194403547873
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rozylo, Jennifer
- Mitchell, Keren
- Nikoo, Mohammadali
- Durante, S. Elise
- Barbic, Skye P.
- Lin, Daniel
- Mathias, Steve
- Azar, Pouya
- SpringerLink (Online service)
Other Objects (12)
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report
Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report
Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report
Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic